Inman Jager Wealth Management’s AbbVie ABBV Stock Holding History

Inman Jager Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$430K	Buy	1,710 +161	+10%	+$34.6K	0.23%	67
2026 Q1	$337K	Hold	1,549	–	–	0.2%	70
2025 Q4	$354K	Hold	1,549	–	–	0.22%	70
2025 Q3	$359K	Buy	1,549 +225	+17%	+$45.8K	0.23%	67
2025 Q2	$246K	Sell	1,324 -1	-0.1%	-$186	0.17%	77
2025 Q1	$278K	Sell	1,325 -59	-4%	-$11.5K	0.21%	69
2024 Q4	$246K	Buy	+1,384	New	+$254K	0.19%	71

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Inman Jager Wealth Management's ABBV Position: Q2 2026 in Review

Inman Jager Wealth Management increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $34.6K and bringing the position to 1,710 shares worth $430K. The position accounts for 0.23% of the portfolio, ranked #67.

Inman Jager Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Inman Jager Wealth Management held 1,710 shares of AbbVie worth $430K as of Q2 2026.
Inman Jager Wealth Management bought 161 AbbVie shares in Q2 2026, an estimated $34.6K.
AbbVie made up 0.23% of Inman Jager Wealth Management's portfolio in Q2 2026, its #67 holding.
Inman Jager Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Inman Jager Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.